Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Reprogrammed human blood cells show promise for disease research

02.07.2010
Cells from frozen human blood samples can be reprogrammed to an embryonic stem-cell-like state, according to Whitehead Institute researchers. These cells can be multiplied and used to study the genetic and molecular mechanisms of blood disorders and other diseases.

RELEVANCE: Blood samples represent an easily accessible source of human cells for research and offer a host of practical advantages over the reliance on skin biopsies to attain cell samples. The breakthrough described here allows for study of cells from frozen blood samples already stored at blood banks—even from deceased patients.

CAMBRIDGE, Mass. (July 1, 2010) – Cells from frozen human blood samples can be reprogrammed to an embryonic-stem-cell-like state, according to Whitehead Institute researchers. These cells can be multiplied and used to study the genetic and molecular mechanisms of blood disorders and other diseases.

The research is reported in the July 2 issue of Cell Stem Cell.

To date, most cellular reprogramming has relied on skin biopsy or the use of stimulating factors to obtain the cells for induction of pluripotency. This work shows for the first time that cells from blood samples commonly drawn in doctor's offices and hospitals can be used to create induced pluripotent stem (iPS) cells.

Using blood as a cell source of iPS cells has two major advantages.

"Blood is the easiest, most accessible source of cells, because you'd rather have 20 milliliters of blood drawn than have a punch biopsy taken to get skin cells," says Judith Staerk, first author of the Cell Stem Cell paper and a postdoctoral researcher in the lab of Whitehead Founding Member Rudolf Jaenisch.

Also, blood collection and storage is a well established part of the medical system.

"There are enormous resources—blood banks with samples from patients—that may hold the only viable cells from patients who may not be alive anymore or from the early stage of their diseases," says Jaenisch, who is also a professor of biology at MIT. "Using this method, we can now resurrect those cells as induced pluripotent stem cells. If the patient had a neurodegenerative disease, you can use the iPS cells to study that disease."

iPS cells are reprogrammed from an adult state to an embryonic stem-cell-like state by inserting four reprogramming genes into the adult cells' DNA. These reprogramming factors convert the adult cells, with defined cell functions, into much more flexible iPS cells. iPS cells can then be nudged to divide repeatedly or turn into almost any cell type found in the body, allowing scientists to create large amounts of the specific cells needed to study a disease, such as dopamine-producing neurons for Parkinson's disease research.

Unlike other cell types, human blood cells had proven extremely difficult to convert into iPS cells. Working with frozen blood samples similar to those found in a blood bank, Staerk found that she could convert the blood cells by inserting a "cassette" of the reprogramming factors end to end, rather than inserting each of the factors separately.

Not all of the cells in the blood samples were converted to iPS cells. Blood is composed of red cells that carry oxygen throughout the body, white cells that are part of the immune system, and platelets that clot the blood after an injury. Because red blood cells and platelets lack nuclei containing DNA, they cannot be converted to iPS cells. The only white bloods cells converted to iPS cells were T cells and a few myeloid cells. B cells failed to reprogram, most likely because the experiment's environment lacked the chemicals needed for successful B-cell conversion.

Staerk is particularly interested in using these iPS cells to study blood diseases.

"With this method, you could reprogram blood samples from patients where the underlying cause of their diseases is not known, and get cell numbers large enough to screen for genetic factors and study the molecular mechanisms underlying the blood disorders," she says. "That's a big advance, especially if the patient is not alive anymore and new material cannot be obtained."

This research was supported by the National Institutes of Health (NIH) and the Human Frontier Science Program (HFSP).

Rudolf Jaenisch's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology at Massachusetts Institute of Technology.

Full Citations:

"Reprogramming of human peripheral blood cells to induced pluripotent stem cells"

Cell Stem Cell, July 2, 2010.

Judith Staerk (1), Meelad M. Dawlaty (1), Qing Gao (1) Dorothea Maetzel (1) Jacob Hanna (1), Cesar A. Sommer (2), Gustavo Mostoslavsky (2), and Rudolf Jaenisch (1,3).

1. The Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
2. Section of Gastroenterology, Department of Medicine and Center for Regenerative Medicine (CReM), Boston University School of Medicine, Boston, MA 02118, USA.

3. Department of Biology, Massachusetts Institute of Technology, 31 Ames Street, Cambridge, MA 02139, USA.

Nicole Giese | EurekAlert!
Further information:
http://www.wi.mit.edu

More articles from Life Sciences:

nachricht Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex

nachricht New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Graphene assembled film shows higher thermal conductivity than graphite film

22.06.2018 | Materials Sciences

Fast rising bedrock below West Antarctica reveals an extremely fluid Earth mantle

22.06.2018 | Earth Sciences

Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View

22.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>